A study to learn about the effect and safety of oral zavegepant in participants with mild allergic asthma
A Phase 1b, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Safety and Efficacy of Oral Zavegepant in Subjects With Mild Allergic Asthma
Category & Conditions: Respiratory Disease
Medicine: ZAVZPRET™(ZAVEGEPANT)
ClinicalTrials.gov Identifier (NCT): NCT04987944
Protocol ID: C5301005
Open Plain Language Summary Result:
Click here